Coeptis reverse-merger closes; becomes Z Squared crypto miner; ticker now ZSQR

Z Squared Inc.

Merger closed April 24, 2026; former Coeptis biopharma assets distributed pre-close as dividend to CHI.
Z Squared stockholders received 43,877,497 Coeptis shares (~85% of post-merger equity); control shifted.
New board of five, CEO David Halabu, COO Michelle Burke, CFO Brian Cogley; prior directors/officers resigned.
OpCo mines DOGE and LTC with 9,800 machines (L7, L9, DG1+); valuation ~$660M as of Jan 2025.
Energy cost fixed at $0.088/kWh; mined assets converted to fiat within two weeks to limit volatility.

item 2.01 item 5.01 item 5.02 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Z Squared Inc.: Amended certificate of incorporation to change company name from Coeptis Therapeutics Holdings, Inc. to Z Squared Inc (effective 2026-04-27).

Change: charter amendment
Effective: 2026-04-27

Exact text from the filing

On April 27, 2026, we amended our certificate of incorporation to change the name of the company from Coeptis Therapeutics Holdings, Inc. to "Z Squared Inc."

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

Z Squared Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-003388

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.